Cynthia Butitta reports Autolus (AUTL) share and option holdings on Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Autolus Therapeutics plc director Cynthia M. Butitta filed an initial ownership report showing her equity position in the company. She directly holds 10,000 American Depositary Shares, each convertible into one Ordinary Share, and a series of share options over additional American Depositary Shares with exercise prices ranging from $2.38 to $30.24 and expirations extending through 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
BUTITTA CYNTHIA M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 10,000 shares (Direct);
Share Option (right to buy) — 47,095 shares (Direct)
Footnotes (1)
- Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share. Fully vested and exercisable. This option vested or vests in twelve equal monthly installments commencing on July 26, 2025.
FAQ
What does the Form 3 filed for Autolus Therapeutics (AUTL) by Cynthia M. Butitta show?
The Form 3 shows Cynthia M. Butitta’s initial ownership in Autolus Therapeutics. She reports holding 10,000 American Depositary Shares and multiple share option grants over additional ADSs, establishing her starting equity position as a director of the company.
Does the Autolus Therapeutics (AUTL) Form 3 indicate recent buying or selling by Cynthia M. Butitta?
The disclosure reflects holdings rather than recent buying or selling activity. The entries are categorized as holdings with no buy or sell transaction codes, indicating an initial statement of beneficial ownership instead of a new market transaction.
What is the significance of the exercise prices on Cynthia M. Butitta’s Autolus Therapeutics (AUTL) options?
The exercise prices define the cost to acquire Autolus American Depositary Shares under each option. They range from $2.38 to $30.24 per share, and combined with long-dated expirations, they outline the potential future equity she can purchase.